RFC
COLL icon

Russell Frank Company’s Collegium Pharmaceutical COLL Stock Holding History

Russell Frank Company’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$422K Sell
23,263
-11,659
-33% -$212K ﹤0.01% 2509
2015
Q4 		$1M Hold
34,922
– – ﹤0.01% 2204
2015
Q3 		$772K Buy
+34,922
New +$631K ﹤0.01% 2312

Other funds holding COLL

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Russell Frank Company's COLL Position: Q1 2016 in Review

Russell Frank Company reduced its Collegium Pharmaceutical (COLL) stake by 33% in Q1 2016, selling an estimated $212K and leaving 23,263 shares worth $422K. The position accounts for ﹤0.01% of the portfolio, ranked #2509.

Russell Frank Company first reported a position in COLL in Q3 2015 and has held it in 3 quarters since. The position peaked at $1M in Q4 2015. 70 funds tracked by Wall St. Rank hold COLL as of Q1 2016.

  • Russell Frank Company held 23,263 shares of Collegium Pharmaceutical worth $422K as of Q1 2016.
  • Russell Frank Company sold 11,659 Collegium Pharmaceutical shares in Q1 2016, an estimated $212K.
  • Collegium Pharmaceutical made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #2509 holding.
  • Russell Frank Company first reported a position in Collegium Pharmaceutical in Q3 2015 and has held it in 3 quarters since.
  • Russell Frank Company's Collegium Pharmaceutical position peaked at $1M in Q4 2015.
  • 70 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.